CARL (Carlsmed Corp) Market Value to Book Value Ratio

Carlsmed Corp - graphic logo of issuer CARL

Carlsmed Inc (CARL) specializes in the creation of personalized spinal implants. The stock price history visualizes the impact of stringent FDA requirements and patent protection for AI solutions on quotes, which currently stand at 4.96. Localizing 3D printing at points of sale reduces logistics, while a steady flow of polymers ensures operational continuity. An eco-friendly approach minimizes product surpluses, ensuring product durability in accordance with ESG standards.

Carlsmed Medical (CARL) Market Capitalization to Net Assets: for the period 07/24/2025 - 10/29/2026

Analytical breakdowns and data insights for company Carlsmed, Inc. (CARL)

- market value and analyst target forecast:
Price Chart Carlsmed Inc|CARL - Price Target Chart
- business market valuation indicators:
Market Value Carlsmed Corp|CARL - Company Buyout Price
- book capitalization data:
Net Assets per Single Share Carlsmed|CARL - Net Asset Value|Market Capitalization to Book Value Ratio carlsmed.com|CARL - Company Assets
- debt level and financial liquidity data:
Total Debt to Capital Carlsmed Inc|CARL - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Carlsmed Corp|CARL - Company Total Debt Obligations|Debts to Book Capitalization Carlsmed Corp|CARL - Company Long-Term Debts|Company Short-Term Debt Carlsmed
Analysis of all company metrics:Carlsmed Inc - CARL
Flagship merchandise of Carlsmed, Inc.

Carlsmed Inc (CARL) leadership in personalized spine surgery and physician trust in its AI-driven implants create significant intangible business value. Analyzing the company's price-to-book ratio reveals a market price premium over net assets, which signals overvaluation in the context of low ROE, while increasing efficiency confirms a fair discount for technological superiority.

Competitor analysis

Boston Scientific (BSX) - Market Value to Book Value Ratio|EW (edwards.com) - Market Value to Book Value Ratio|Market Value to Book Value Ratio ResMed|Insulet Corp (PODD) - Market Capitalization to Book Value|Market Value to Book Value Ratio Zimmer Biomet Holdings, Inc. (ZBH)|COO: Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio ALGN (Align Technology, Inc.)|globusmedical.com (GMED) - Market-to-Book Ratio|TransMedics Group - Market Capitalization to Book Value Ratio|Alphatec Holdings (ATEC) - Market Cap to Net Assets Ratio|AORT: Market Capitalization to Book Value Ratio|ENOV - Market Capitalization to Book Value|IART (Integra LifeSciences) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio establishmentlabs.com|Market Value to Book Value Ratio Beta Bionics (BBNX)|Market Value to Book Value Ratio IRMD (IRADIMED Corp)|Market Capitalization to Book Value Ratio EMBC (Embecta Inc.)|Market Capitalization to Book Value Tandem Corp (TNDM)|AXGN: Market Cap to Net Assets Ratio|Market Capitalization to Net Assets SIBN|OFIX: Market Capitalization to Book Value Ratio|Market-to-Book Ratio Bioventus Inc (BVS)|KIDS (OrthoPediatrics Corp) - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio TMCI (Treace Corp)|Market Cap to Net Assets Ratio SRTA (Strata Critical Medical Inc)|RXST (rxsight.com) - Market Value to Book Value|Market Value to Book Value Ratio ClearPoint Neuro CLPT|STXS - Market Cap to Net Assets Ratio|NeuroStar - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Sight Sciences Inc|OBIO: Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio ANIK|NSPR (InspireMD) - Market Capitalization to Book Value Ratio|Jin Medical International Ltd (ZJYL) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio VANI|Market Cap to Net Assets Ratio xtantmedical.com XTNT|Market Capitalization to Book Value Ratio NMTC (NeuroOne Medical Technologies)|Market Capitalization to Book Value Ratio Modular Medical Inc MODD|MYO - Market Value to Book Value Ratio|COCH: Market Value to Book Value Ratio|VVOS (Vivos Therapeutics, Inc) - Market Cap to Net Assets Ratio|enVVeno Corp - Market Value to Book Value|SINT (Sintx Technologies Inc) - Market Capitalization to Book Value Ratio|Market-to-Book Ratio tenonmed.com TNON|Market Value to Book Value Ratio Lifeward (LFWD)|autonomix.com (AMIX) - Market Value to Equity Ratio|INVO Bioscience, Inc. - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio Bone Biologics Inc BBLG|Axonics, Inc. - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value biolase.com BIOL|dynatronics.com (DYNT) - Market Value to Book Value Ratio|Market Capitalization to Net Assets FNA (Paragon 28)|Market Value to Book Value Ratio INVO Bioscience Inc.